What You Should Know:
The Strategic Pivot Validated: Weight Watchers (WW) has released GLP-1 Results Report validating its integrated weight health platform, which combines medical therapy with behavioral support.The Core Data: Members who actively paired weight loss medication with the WW GLP-1 Success Program achieved 61.3% greater average weight loss in their first month compared to those who did not engage in behavioral support.Long-Term Efficacy: WW Med+ members prescribed GLP-1s reached
Read More
GLP-1
Walgreens Launches $49 Pay-Per-Visit Weight Management, Expanding Virtual Healthcare Platform
What You Should Know
The Launch: Walgreens has officially launched Walgreens Weight Management, expanding its Virtual Healthcare platform to offer personalized, clinician-guided weight loss support for eligible adults ages 18-64.The Clinical Pathway: Eligible patients complete an online video visit with a licensed doctor or nurse practitioner who evaluates their medical history and goals. Providers can then prescribe FDA-approved GLP-1 medications (like Wegovy) for weight loss.The Pricing
Read More
GLP-1: Amazon Pharmacy Adds Zepbound KwikPen to Its Same-Day Delivery for $299
What You Should Know
The Launch: Amazon Pharmacy has officially expanded its weight management portfolio by adding Eli Lilly's Zepbound® KwikPen® to its digital shelves.The Hardware: Unlike traditional single-use GLP-1 auto-injectors, the KwikPen is a multi-dose device designed to deliver a full month of medication in a single pen, reducing medical waste and simplifying the patient experience.The Disruption: Bypassing the murky world of Pharmacy Benefit Managers (PBMs), Amazon is offering
Read More
Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients
What You Should Know
The Launch: Walgreens has expanded its virtual healthcare platform to include Walgreens Weight Management, a digital clinic connecting eligible adults (18-64) with doctors or nurse practitioners to obtain FDA-approved weight loss medications.The Pricing Model: In a direct shot at subscription-heavy telehealth competitors, Walgreens is charging a flat $49 per visit with zero monthly subscription fees.The Target Audience: The service is explicitly designed for the
Read More
How Employers Can Save $550/Month on GLP-1s: Introducing Vida Self-Pay
What You Should Know
- Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs).
- By combining virtual, whole-person clinical care with transparent "cash-price" subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to GLP-1s and other AOMs.
Bypassing the PBM "Walled Garden"
The Vida Self-Pay model functions as a
Read More
Noom Pivots to Longevity: New Program Combines Microdose GLP-1s with At-Home Biomarker Testing
What You Should Know:
- Noom has launched Proactive Health Microdose GLP-1Rx, a first-of-its-kind preventive health program designed to intervene before chronic disease takes root.
- Available to individuals with a BMI of 21 or higher, the offering combines personalized microdoses of GLP-1 medication with comprehensive at-home biomarker testing and Noom’s digital behavior modification platform.
- Priced at $149 per month, the program aims to shift the healthcare paradigm
Read More
PHTI Report 2025: 5 Strategies for Employers to Manage GLP-1 Costs and Coverage
What You Should Know:
- The Peterson Health Technology Institute (PHTI) has released a critical purchasing guide for employers struggling to manage the skyrocketing costs of GLP-1 obesity medications.
- The report recommends a shift away from broad, unchecked coverage toward a managed approach focused on three phases: Initiation (strict eligibility), Maintenance (adherence support), and Supported Discontinuation (managing off-ramps).
- PHTI urges employers to demand
Read More
Castlight and Noom Join Forces to Tackle the GLP-1 Cost Crisis Through Integrated Digital Health
What You Should Know:
- Castlight Health and Noom have formed a strategic partnership to embed Noom’s preventive health and weight management programs directly into Castlight’s health navigation platform.
- The integration allows employers to purchase Noom through Castlight, granting employees seamless access to psychology-based care and GLP-1 medication management. The move is designed to combat rising healthcare costs by pairing expensive pharmaceutical interventions with
Read More
Dietitian Live’s Quantum Mind Architecture™: How Subconscious Rewiring is Reversing Type 2 Diabetes Without GLP-1s
What You Should Know:
- Dietitian Live, a pioneering healthcare startup, today announced a breakthrough demonstrating that subconscious belief patterns are the primary driver of healing in chronic metabolic disease.
- Its patent-pending Quantum Mind Architecture™ program achieved an 81% reversal to normal A1C levels in pre-diabetes and 28% reversal in Type 2 Diabetes without GLP-1s in a same-cohort study. The company is advocating for the creation of a new field: subconscious
Read More
GoodRx Launches $199 Ozempic and Wegovy Pricing, Unveils Telemedicine for GLP-1 Access
What You Should Know:
- GoodRx has unveiled two major initiatives to democratize access to GLP-1 medications: the launch of the GoodRx for Weight Loss telemedicine subscription and a new introductory cash price of $199 per month for Ozempic® and Wegovy® injection pens through a partnership with Novo Nordisk.
GoodRx for Weight Loss Telemedicine
GoodRx for Weight Loss, a direct-to-consumer telemedicine subscription is designed to simplify and manage every step of the GLP-1 treatment
Read More
